NDC 10122-325

Cardene IV

Nicardipine Hydrochloride

Cardene IV is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Chiesi Usa, Inc.. The primary component is Nicardipine Hydrochloride.

Product ID10122-325_35a66ebb-329c-49ad-a047-9c0bf15e8028
NDC10122-325
Product TypeHuman Prescription Drug
Proprietary NameCardene IV
Generic NameNicardipine Hydrochloride
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date1992-01-30
Marketing End Date2022-06-30
Marketing CategoryNDA / NDA
Application NumberNDA019734
Labeler NameChiesi USA, Inc.
Substance NameNICARDIPINE HYDROCHLORIDE
Active Ingredient Strength0 mg/mL
Pharm ClassesCalcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA]
NDC Exclude FlagN

Packaging

NDC 10122-325-10

10 CARTON in 1 BOX (10122-325-10) > 1 BAG in 1 CARTON (10122-325-01) > 200 mL in 1 BAG
Marketing Start Date1992-01-30
Marketing End Date2022-06-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 10122-325-01 [10122032501]

Cardene IV INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019734
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1992-01-30
Marketing End Date2022-06-30

NDC 10122-325-10 [10122032510]

Cardene IV INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA019734
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date1992-01-30
Marketing End Date2022-06-30

Drug Details

Active Ingredients

IngredientStrength
NICARDIPINE HYDROCHLORIDE.2 mg/mL

OpenFDA Data

SPL SET ID:0d58f812-37bf-439f-b3f2-c31f8eefe22e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 858605
  • 858601
  • 858599
  • 858603
  • Pharmacological Class

    • Calcium Channel Antagonists [MoA]
    • Dihydropyridine Calcium Channel Blocker [EPC]
    • Dihydropyridines [CS]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 2D6 Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]
    • Cytochrome P450 2C19 Inhibitors [MoA]

    NDC Crossover Matching brand name "Cardene IV" or generic name "Nicardipine Hydrochloride"

    NDCBrand NameGeneric Name
    10122-313Cardene IVnicardipine hydrochloride
    10122-314Cardene IVnicardipine hydrochloride
    10122-325Cardene IVnicardipine hydrochloride
    43066-009CARDENE IVnicardipine hydrochloride
    43066-016CARDENE IVnicardipine hydrochloride
    43066-021Cardene IVnicardipine hydrochloride
    0143-9542Nicardipine HydrochlorideNicardipine Hydrochloride
    0143-9593Nicardipine HydrochlorideNicardipine Hydrochloride
    0143-9633Nicardipine HydrochlorideNicardipine Hydrochloride
    0143-9634Nicardipine HydrochlorideNicardipine Hydrochloride
    0143-9689Nicardipine HydrochlorideNicardipine Hydrochloride
    0378-1020Nicardipine Hydrochloridenicardipine hydrochloride
    0378-1430Nicardipine Hydrochloridenicardipine hydrochloride
    0517-0735Nicardipine Hydrochloridenicardipine hydrochloride
    0781-3204Nicardipine HydrochlorideNicardipine Hydrochloride
    0781-9324Nicardipine HydrochlorideNicardipine Hydrochloride
    14593-124Nicardipine HydrochlorideNicardipine Hydrochloride
    24658-750Nicardipine HydrochlorideNicardipine Hydrochloride
    24658-751Nicardipine HydrochlorideNicardipine Hydrochloride
    40042-047Nicardipine HydrochlorideNicardipine Hydrochloride
    42806-501Nicardipine HydrochlorideNicardipine Hydrochloride
    42806-502Nicardipine HydrochlorideNicardipine Hydrochloride

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.